Sysco executive Navin Advani holds 6,010 shares

The seven reported option tranches have expiration dates running from August 20, 2029, through August 20, 2035.

Available on EDGAR 11/03/2026 - 04:19 PM EST Accepted by SEC EDGAR 11/03/2026 - 04:19 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

SYSCO CORP (SYY) reports direct holdings for Navin Advani, Executive Vice President, Chief Information and Digital Officer, as of November 1, 2026: 6,010 common shares and seven stock-option tranches to buy common stock. The listed tranches include options for 8,244 shares at a $58.0800 exercise price expiring August 19, 2030, and options for 7,386 shares at $72.8000 expiring August 20, 2029; other listed expirations extend through August 20, 2035.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Advani Navin

Role See Remarks

Type	Security	Shares	Price	Value
Holding	Stock Options (Right to buy) F1	--	--	--
Holding	Stock Options (Right to buy) F2	--	--	--
Holding	Stock Options (Right to buy) F3	--	--	--
Holding	Stock Options (Right to buy) F4	--	--	--
Holding	Stock Options (Right to buy) F5	--	--	--
Holding	Stock Options (Right to buy) F6	--	--	--
Holding	Stock Options (Right to buy) F7	--	--	--
Holding	Common Stock	--	--	--

Holdings: Stock Options (Right to buy) — 32,422 contracts (Direct); Common Stock — 6,010.158 shares (Direct)

Footnotes (7)

1. F1. One-third of the shares covered by the grant vest and are exercisable on 08/21/2020, 08/21/2021 and 08/21/2022, respectively. Options will expire on 08/20/2029.
2. F2. One-third of the shares covered by the grant vest and are exercisable on 08/20/2021, 08/20/2022 and 08/20/2023, respectively. Options will expire on 08/19/2030.
3. F3. One-third of the shares covered by the grant vest and are exercisable on 08/19/2022, 08/19/2023 and 08/19/2024, respectively. Options will expire on 08/18/2031.
4. F4. One-third of the shares covered by the grant vest and are exercisable on 08/18/2023, 08/18/2024 and 08/18/2025, respectively. Options will expire on 08/17/2032.
5. F5. One-third of the shares covered by the grant vest and are exercisable on 8/10/2024, 8/10/2025 and 8/10/2026, respectively. Options will expire on 8/9/2033.
6. F6. One-third of the shares covered by the grant vest and are exercisable on 8/21/2025, 8/21/2026 and 8/21/2027, respectively. Options will expire on 8/20/2034.
7. F7. One-third of the shares covered by the grant vest and are exercisable on 8/21/2026, 8/21/2027 and 8/21/2028, respectively. Options will expire on 8/20/2035.

Key Figures

Direct common shares held: 6,010 shares Options to buy common stock: 7,386 shares Options to buy common stock: 8,244 shares +5 more

8 metrics

Direct common shares held 6,010 shares As of November 1, 2026

Options to buy common stock 7,386 shares Exercise price $72.8000; expires August 20, 2029

Options to buy common stock 8,244 shares Exercise price $58.0800; expires August 19, 2030

Options to buy common stock 4,090 shares Exercise price $76.9400; expires August 18, 2031

Options to buy common stock 2,923 shares Exercise price $85.5700; expires August 17, 2032

Options to buy common stock 3,004 shares Exercise price $73.5300; expires August 9, 2033

Options to buy common stock 3,240 shares Exercise price $76.5400; expires August 20, 2034

Options to buy common stock 3,535 shares Exercise price $80.9800; expires August 20, 2035

Key Terms

Stock Options (Right to buy), vest, exercisable

3 terms

Stock Options (Right to buy) financial

"Stock Options (Right to buy)"

vest financial

"shares covered by the grant vest"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

exercisable financial

"vest and are exercisable"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SYY common shares does Navin Advani report holding?

Navin Advani directly holds 6,010 common shares as of November 1, 2026.

What are Navin Advani's SYY stock-option exercise prices and expiration dates?

The other listed tranches include options for 4,090 shares at $76.9400, expiring August 18, 2031; 2,923 at $85.5700, expiring August 17, 2032; 3,004 at $73.5300, expiring August 9, 2033; 3,240 at $76.5400, expiring August 20, 2034; and 3,535 at $80.9800, expiring August 20, 2035.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Advani Navin

(Last) (First) (Middle)

1390 ENCLAVE PARKWAY

(Street)

HOUSTON TEXAS 77077

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
11/01/2026

3. Issuer Name and Ticker or Trading Symbol
SYSCO CORP [ SYY ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	6,010.158	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to buy)	(1)	08/20/2029	Common Stock	7,386	$72.8	D
Stock Options (Right to buy)	(2)	08/19/2030	Common Stock	8,244	$58.08	D
Stock Options (Right to buy)	(3)	08/18/2031	Common Stock	4,090	$76.94	D
Stock Options (Right to buy)	(4)	08/17/2032	Common Stock	2,923	$85.57	D
Stock Options (Right to buy)	(5)	08/09/2033	Common Stock	3,004	$73.53	D
Stock Options (Right to buy)	(6)	08/20/2034	Common Stock	3,240	$76.54	D
Stock Options (Right to buy)	(7)	08/20/2035	Common Stock	3,535	$80.98	D

Explanation of Responses:

1. One-third of the shares covered by the grant vest and are exercisable on 08/21/2020, 08/21/2021 and 08/21/2022, respectively. Options will expire on 08/20/2029.

2. One-third of the shares covered by the grant vest and are exercisable on 08/20/2021, 08/20/2022 and 08/20/2023, respectively. Options will expire on 08/19/2030.

3. One-third of the shares covered by the grant vest and are exercisable on 08/19/2022, 08/19/2023 and 08/19/2024, respectively. Options will expire on 08/18/2031.

4. One-third of the shares covered by the grant vest and are exercisable on 08/18/2023, 08/18/2024 and 08/18/2025, respectively. Options will expire on 08/17/2032.

5. One-third of the shares covered by the grant vest and are exercisable on 8/10/2024, 8/10/2025 and 8/10/2026, respectively. Options will expire on 8/9/2033.

6. One-third of the shares covered by the grant vest and are exercisable on 8/21/2025, 8/21/2026 and 8/21/2027, respectively. Options will expire on 8/20/2034.

7. One-third of the shares covered by the grant vest and are exercisable on 8/21/2026, 8/21/2027 and 8/21/2028, respectively. Options will expire on 8/20/2035.

Remarks:

Title: Executive Vice President, Chief Information and Digital Officer; Exhibit List: Exhibit 24.1 Power of Attorney

	/s/ Boyd Chapin, Attorney-in-Fact	11/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)